FDA Will Face Reforms, Oversight In Republican Congress, Analysts Say
This article was originally published in The Gray Sheet
Executive Summary
Election gains by Republicans will embolden Congress to put FDA in its oversight “crosshairs,” as members of key Senate and House panels scrutinize how the agency is using its resources. Reforms could also come soon as part of the ongoing 21st Century Cures initiative.